GS
AUGX

George Soros’s Augmedix, Inc. Common Stock AUGX Stock Holding History

George Soros’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-88,516
Closed -$518K – 267
2023
Q4 		$518K Buy
+88,516
New +$466K 0.01% 202

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

George Soros's AUGX Position: Q1 2024 in Review

George Soros sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 88,516 shares — an estimated $518K sold.

George Soros first reported a position in AUGX in Q4 2023 and held it in 1 quarter. The position peaked at $518K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • George Soros reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • George Soros sold 88,516 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $518K.
  • George Soros first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • George Soros's Augmedix, Inc. Common Stock position peaked at $518K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.